Screening for Prostate Cancer | CTFPHC

Index

1.Summary
2.Clinician Summary
3.Prostate Cancer Infographic
4.1000-Person Tool
5.Patient FAQ
6.Clinician Recommendations - Full (CMAJ)
7.CTFPHC Prostate-Specific Antigen Screening Video
8.Mike Evans Screening Video

Summary of recommendations for clinicians and policy-makers

This clinical practice guideline applies to all men not previously diagnosed with prostate cancer. This includes men with lower urinary tract symptoms (nocturia, urgency, frequency and poor stream) or with benign prostatic hyperplasia (BPH). The CTFPHC will continue to carefully monitor the scientific development in prostate cancer screening and report back to Canadians within 5 years with an update of the 2014 Prostate Cancer Screening guideline.

Recommendations

  • For men aged less than 55 years, we recommend not screening for prostate cancer with the prostate-specific antigen test.
    (Strong recommendation; low quality evidence)
  • For men aged 55–69 years, we recommend not screening for prostate cancer with the prostate-specific antigen test.
    (Weak recommendation; moderate quality evidence)
  • For men 70 years of age and older, we recommend not screening for prostate cancer with the prostate-specific antigen test.
    (Strong recommendation; low quality evidence)
Created by

By using this site you acknowledge that you have read, understand, and agree to be bound by our terms of use and privacy policy. All content and tools are for educational use only, are not meant to be a substitute for professional advice and should not be used for medical diagnosis and/or medical treatment.